KEISHA PERRY: Open Payments
NPI 1447628458 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$169 in 8 payments from 6 companies in 2025. Trend: 2023 $81 · 2024 $407 · 2025 $169
Food & beverage: $169
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $19 |
Products named: Veozah, AJOVY, TRINTELLIX, RELISTOR, REXULTI, WaveWriter Alpha Prime 16.
Industry payments across DE — which companies pay providers there.
